PubMed · 16098417
Revascularization in severe left ventricular dysfunction: the role of viability testing.
Abstract
Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Panithaya Chareonthaitawee, Bernard J Gersh, Philip A Araoz, Raymond J Gibbons. 2005-08-16. Revascularization in severe left ventricular dysfunction: the role of viability testing.. https://doi.org/10.1016/j.jacc.2005.03.072
Cite the original work for its findings. Save a collection to share your selection of sources.